Self-Assembly of Peptides into Spherical Nanoparticles for Delivery of Hydrophilic Moieties to the Cytosol
Source abstract
Abstract
We report a novel class of self-assembling peptide nanoparticles formed by mixing aqueous solutions of K(16) peptide and a 20 amino acid peptide of net charge -5 (GLFEALLELLESLWELLLEA). Particle formation is salt-dependent and yields perfectly spherical nanoparticles of approximately 120 to approximately 800 nm diameter, depending on buffer composition and temperature, with a stoichiometry of approximately 1:2.5 for the cationic and anionic peptides. The anionic peptide forms an alpha-helix in aqueous solution, has all five glutamates on one side of the helix, and exists entirely as a discrete oligomer of 9-10 peptides. A rigid oligomer with 45-50 negative charges almost certainly represents the core component of these nanoparticles, held together by electrostatic interactions with the unstructured K(16) peptide. Cells internalize these particles by an endocytic process, and free particles are frequently seen in the cytosol, presumably because of the acid-dependent fusogenic properties of the anionic peptide. Among other applications, these particles have potential for the targeted delivery of single or multiple therapeutic moieties directly to the cytosol, and we report the successful delivery of a K(16)-linked pro-apoptosis peptide.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Supramolecular Self-Assembly in Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Clinical Sciences, King’s College London School of Medicine, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU England
School of Chemistry, Bio21 Institute, University of Melbourne, Melbourne VIC 3010, Australia
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Victoria 3010, Australia
References (37)
Show source-provided references
1. Shevchenko E. V. · Nature · 2006 · 439 · 5510.1038/nature04414 ↗
2. Percec V. · Nature · 2004 · 430 · 76410.1038/nature02770 ↗
3. O’Reilly R. K. · Philos. Trans. A · 2007 · 365 · 286310.1098/rsta.2007.0019 ↗
4. Bognolo G. · Adv. Colloid Interface Sci. · 2003 · 106 · 16910.1016/j.cis.2003.07.002 ↗
5. Wright E. R. · Adv. Drug Delivery Rev. · 2002 · 54 · 105710.1016/S0169-409X(02)00059-5 ↗
6. Kalsin A. M. · Science · 2006 · 312 · 42010.1126/science.1125124 ↗
7. Kalsin A. M. · Nano Lett. · 2007 · 7 · 101810.1021/nl0701915 ↗
8. Bishop K. J. · ChemPhysChem · 2007 · 8 · 217110.1002/cphc.200700349 ↗
9. Yang Y. · Nano Today · 2009 · 4 · 19310.1016/j.nantod.2009.05.001 ↗
10. Parker A. L. · J. Gene Med. · 2005 · 7 · 154510.1002/jgm.809 ↗
11. Lear J. D. · J. Biol. Chem. · 1987 · 262 · 650010.1016/S0021-9258(18)48270-1 ↗
12. Skehel J. J. · Biochem. Soc. Trans. · 2001 · 29 · 62310.1042/bst0290623 ↗
13. Gottschalk S. · Gene Ther. · 1996 · 3 · 448
14. Fabre J. W. · Curr. Gene Ther. · 2006 · 6 · 45910.2174/156652306777934865 ↗
15. Chauhan A. · J. Controlled Release · 2007 · 117 · 14810.1016/j.jconrel.2006.10.031 ↗
16. Futaki S. · J. Biol. Chem. · 2001 · 276 · 583610.1074/jbc.M007540200 ↗
17. Mäe M. · Curr. Opin. Pharmacol. · 2006 · 6 · 50910.1016/j.coph.2006.04.004 ↗
18. Zorko M. · Adv. Drug Delivery Rev. · 2005 · 57 · 52910.1016/j.addr.2004.10.010 ↗
19. Chen L. · Biochem. Soc. Trans. · 2007 · 35 · 82110.1042/BST0350821 ↗
20. Wadia J. S. · Nat. Med. · 2004 · 10 · 31010.1038/nm996 ↗
21. Nakase I. · Mol. Ther. · 2004 · 10 · 101110.1016/j.ymthe.2004.08.010 ↗
22. Ziady A. G. · Am. J. Physiol. · 1997 · 273 · G545
23. Scarborough R. M. · J. Biol. Chem. · 1993 · 268 · 105810.1016/S0021-9258(18)54041-2 ↗
24. Shewring L. · Transplantation · 1997 · 64 · 76310.1097/00007890-199709150-00018 ↗
25. Greenspoon N. · Biochemistry · 1993 · 32 · 100110.1021/bi00055a002 ↗
26. Nissinen M. · Biochem. J. · 1991 · 276 · 36910.1042/bj2760369 ↗
27. Chen Y. P. · Proc. Natl. Acad. Sci. U.S.A. · 1999 · 96 · 432510.1073/pnas.96.8.4325 ↗
28. International Standard ISO13321. Methods for Determination of Particle Size Distribution Part 8: Photon Correlation Spectroscopy, International Organisation for Standardisation, 1996.
29. Cornell B. A. · Biochim. Biophys. Acta · 1981 · 642 · 37510.1016/0005-2736(81)90453-3 ↗
30. Hunter R. J. · 1981
31. Gratzer W. B. · 1984 · 1
32. Hayes, D. B.; Laue, T.; Philo, J.SEDNTERP: Interpretation of Sedimentation Data, version v1.09; University of New Hampshire, 2003, http://www.rasmb.bbri.org.
33. Schuck P. · Biopolymers · 2000 · 54 · 32810.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P ↗
34. Schuck P. · Biophys. J. · 2000 · 78 · 160610.1016/S0006-3495(00)76713-0 ↗
35. Humphrey W. · J. Mol. Graphics · 1996 · 14 · 3310.1016/0263-7855(96)00018-5 ↗
36. Phillips J. C. · J. Comput. Chem. · 2005 · 26 · 178110.1002/jcc.20289 ↗
37. Straume M. · Methods Enzymol. · 1992 · 210 · 8710.1016/0076-6879(92)10007-Z ↗